Judge Delays APBiotech Patents Trial Against Applied Bio | GenomeWeb

NEW YORK, Jan 26 - A trial to determine whether a patent Amersham Pharmacia Biotech holds for DNA chemistries is valid and enforceable has been delayed from January 29 until March, AP Biotech said Friday.

The judge in the jury trial, which stems from a lawsuit AP Biotech brought against Applied Biosystems and its sister company Celera, will use the extra time to decide whether the patent issue also includes Applied Biosystems’ soon-to-be-released Version 3 of  its “Big Dye” products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.